Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;8(3):439–447. doi: 10.1111/j.1750-3639.1998.tb00166.x

Microglial Activation in Alzheimer Disease: Association with APOE Genotype

Rupert Egensperger 1, Siegfried Kösel 2, Ulrich von Eitzen 2, Manuel B Graeber 3,✉
PMCID: PMC8098510  PMID: 9669695

Abstract

Microglial cells are considered to play an important role in the pathogenesis of Alzheimer disease. Apart from producing the Alzheimer amyloid precursor (APP) as an acute phase protein, microglial cells seem to be involved in the deposition of its amyloidogenic cleavage product, the amyloid‐β peptide (Aβ). Aβ is bound by apolipoprotein E (APOE) in an isoform‐specific manner, and it has been demonstrated that inheritance of the AD susceptibility allele, APOE ε4, is associated with increased deposition of Aβ in the cerebral cortex. However, the relationship between APOE ε4 gene dose and microglial activation is unknown. Using microglial expression of major histocompatibility complex class II molecules as a marker, we have performed a quantitative genotype‐phenotype analysis on microglial activation in frontal and temporal cortices of 20 APOE genotyped AD brains. The number of activated microglia and the tissue area occupied by these cells increased significantly with APOE ε4 gene dose. When a model of multiple linear regression was used to compare the relative influence of APOE genotype, sex, disease duration, age at death, diffuse and neuritic plaques as well as neurofibrillary tangles on microglial activation, only APOE genotype was found to have a significant effect. Thus, the APOE gene product represents an important determinant of microglial activity in AD. Since microglial activation by APP has been shown to be modulated by apoE in vitro, a direct role of microglia in AD pathogenesis is conceivable.

Full Text

The Full Text of this article is available as a PDF (122.5 KB).

References

  • 1. Alzheimer A (1911) Über eigenartige Krankheitsfälle des späteren Alters. Zeitschr ges Neurol Psych 4: 356–385. [Google Scholar]
  • 2. Ard MD, Cole GM, Wei J, Mehrle AR Fratkin JD (1996) Scavenging of Alzheimer's amyloid beta‐protein by microglia in culture. J Neurosci Res 43: 190–202. [DOI] [PubMed] [Google Scholar]
  • 3. Banati RB, Gehrmann J, Czech C, Manning U, Jones LL, König G, Beyreuther K, Kreutzberg GW (1993) Early and rapid de novo‐synthesis of Alzheimer bA4‐amyloid precursor protein (APP) in activated microglia. Glia 9: 199–210. [DOI] [PubMed] [Google Scholar]
  • 4. Banati RB, Graeber MB (1994) Surveillance, intervention and cytotoxicity: Is there a protective role of microglia Dev Neurosci 16: 114–127. [DOI] [PubMed] [Google Scholar]
  • 5. Barger SW, Harmon AD (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388: 878–881. [DOI] [PubMed] [Google Scholar]
  • 6. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer‐related changes. Acta Neuropathol 82: 239–259. [DOI] [PubMed] [Google Scholar]
  • 7. Breitner JCS (1996) Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisal. Neurobiol Aging 17: 789–794. [DOI] [PubMed] [Google Scholar]
  • 8. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak‐Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921–923. [DOI] [PubMed] [Google Scholar]
  • 9. Curran M, Middleton D, Edwardson J, Perry R, McKeith I, Morris C, Neill D (1997) HLA‐DR antigens associated with major genetic risk for late‐onset Alzheimer's disease. Neuroreport 8: 1467–1469. [DOI] [PubMed] [Google Scholar]
  • 10. De Simone R, Giampaolo A, Giometto B, Gallo P, Levi G, Peschle C, Aloisi F (1995) The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 54: 175–187. [DOI] [PubMed] [Google Scholar]
  • 11. Defigueiredo RJP, Cummings BJ, Mundkur PY, Cotman CW (1995) Color image analysis in neuroanatomical research: Application to senile plaque subtype quantification in Alzheimer's disease. Neurobiol Aging 16: 211–223. [DOI] [PubMed] [Google Scholar]
  • 12. Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56: 321–339. [DOI] [PubMed] [Google Scholar]
  • 13. Dickson DW, Lee SC, Mattiace LA, Yen SHC, Brosnan C (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7: 75–83. [DOI] [PubMed] [Google Scholar]
  • 14. Dickson DW, Sinicropi S, Yen SH, Ko LW, Mattiace LA, Bucala R, Vlassara H (1996) Glycation and microglial reaction in lesions of Alzheimer's disease. Neurobiol Aging 17: 733–743. [DOI] [PubMed] [Google Scholar]
  • 15. Egensperger R, Kösel S, Mehraein P, Graeber MB (1995) Apolipoprotein E genotype and neuropathological phenotype in sporadic Alzheimer's disease. Soc Neurosci Abstr 21: 1485. [DOI] [PubMed] [Google Scholar]
  • 16. Egensperger R, Kösel S, Schnabel R, Mehraein P, Graeber MB (1995) Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14‐linked early onset Alzheimer's disease. Acta Neuropathol 90: 257–265. [DOI] [PubMed] [Google Scholar]
  • 17. ElKhoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD (1996) Scavenger receptor‐mediated adhesion of microglia to beta‐amyloid fibrils. Nature 382: 716–719. [DOI] [PubMed] [Google Scholar]
  • 18. Ford AL, Foulcher E, Lemckert FA, Sedgwick JD (1996) Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 184: 1737–1745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Frade JM, Barde YA. Microglia‐derived nerve growth factor causes cell death in the developing retina. Neuron 20: 35–41. [DOI] [PubMed] [Google Scholar]
  • 20. Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D, Li X, Kirkpatrick JB (1995) Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 27: 119–137. [DOI] [PubMed] [Google Scholar]
  • 21. Graeber MB, Bise K, Mehraein P (1994) CR3/43, a marker for activated human microglia: application to diagnostic neuropathology. Neuropathol Appl Neurobiol 20: 406–408. [DOI] [PubMed] [Google Scholar]
  • 22. Graeber MB, Streit WJ, Kreutzberg GW (1988) The microglial cytoskeleton: vimentin is localized within activated cells in situ. J Neurocytol 17: 573–580. [DOI] [PubMed] [Google Scholar]
  • 23. Griffin WST, Sheng JG, Roberts GW, Mrak RE (1995) Interleukin‐1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 54: 276–281. [DOI] [PubMed] [Google Scholar]
  • 24. Hardy J (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20: 154–159. [DOI] [PubMed] [Google Scholar]
  • 25. Haruda FD (1995) Nonsteroidal anti‐inflammatory drugs in Alzheimer's disease. Neurology 45: 2116–2116. [DOI] [PubMed] [Google Scholar]
  • 26. Konno H, Yamamoto T, Iwasaki Y, Saitoh T, Suzuki H, Terunuma H (1989) la‐expressing microglial cells in experimental allergic encephalomyelitis in rats. Acta Neuropathol 77: 472–479. [DOI] [PubMed] [Google Scholar]
  • 27. Kösel S, Graeber MB (1994) Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction. Acta Neuropathol 88: 19–25. [DOI] [PubMed] [Google Scholar]
  • 28. Kreutzberg GW (1996) Microglia ‐ a sensor for pathological events in the CNS. Trends Neurosci 19: 312–318. [DOI] [PubMed] [Google Scholar]
  • 29. LaDu MJ, Pederson TM, Frail DE, Reardon CA, Getz GS, Falduto MT (1995) Purification of apolipoprotein E attenuates isoform‐specific binding to beta‐amyloid. J Biol Chem 270: 9039–9042. [DOI] [PubMed] [Google Scholar]
  • 30. Laskowitz DT, Goel S, Bennett ER, Matthew WD (1997) Apolipoprotein E suppresses glial cell secretion of TNF alpha. J Neuroimmunol 76: 70–74. [DOI] [PubMed] [Google Scholar]
  • 31. LeBlanc AC, Xue R, Gambetti P (1996) Amyloid precursor protein metabolism in primary cell cultures of neurons, astrocytes, and microglia. J Neurochem 66: 2300–2310. [DOI] [PubMed] [Google Scholar]
  • 32. Li YM, Dickson D, Vlassara H (1996) Enhanced binding of advanced glycation endproducts (AGE) by apo E4 isotype links mechanisms of plaque deposition in Alzheimer's disease. FASEB J 10: A677. [DOI] [PubMed] [Google Scholar]
  • 33. Mackenzie IRA, Hao CH, Munoz DG (1995) Role of microglia in senile plaque formation. Neurobiol Aging 16: 797–804. [DOI] [PubMed] [Google Scholar]
  • 34. Mazur‐Kolecka B, Frackowiak J, Le Vinelll H, Haske T, Wisniewski HM (1997) Factors produced by activated macrophages reduce accumulation of Alzheimer's beta‐amyloid protein in vascular smooth muscle cells. Brain Res 760: 255–260. [DOI] [PubMed] [Google Scholar]
  • 35. McDonald DR, Brunden KR, Landreth GE (1997) Amyloid fibrils activate tyrosine kinase‐dependent signaling and superoxide production in microglia. J Neurosci 17: 2284–2294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285–1291. [DOI] [PubMed] [Google Scholar]
  • 37. McGeer PL, Itagaki S, McGeer EG (1988) Expression of the histocompatibility glycoprotein HLA‐DR in neurological disease. Acta Neuropathol 76: 550–557. [DOI] [PubMed] [Google Scholar]
  • 38. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG (1993) Microglia in degenerative neurological disease. Glia 7: 84–92. [DOI] [PubMed] [Google Scholar]
  • 39. Meda L, Cassatella MA, Szendrei Gl, Otvos L, Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglial cells by beta‐amyloid protein and interferon‐gamma. Nature 374: 647–650. [DOI] [PubMed] [Google Scholar]
  • 40. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479–486. [DOI] [PubMed] [Google Scholar]
  • 41. Nakai M, Kawamata T, Taniguchi T, Maeda K, Tanaka C (1996) Expression of apolipoprotein E mRNA in rat microglia. Neuroscience Letters 1: 41–44. [DOI] [PubMed] [Google Scholar]
  • 42. Paresce DM, Ghosh RN, Maxfield FR (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta‐protein via a scavenger receptor. Neuron 17: 553–565. [DOI] [PubMed] [Google Scholar]
  • 43. Perlmutter LS, Scott SA, Barron E, Chui HC (1992) MHC class II‐positive microglia in human brain: Association with Alzheimer lesions. J Neurosci Res 33: 549–558. [DOI] [PubMed] [Google Scholar]
  • 44. Qiu WQ, Ye Z, Kholodenko D, Seubert P, Selkoe DJ (1997) Degradation of amyloid beta‐protein by a metallo‐protease secreted by microglia and other neural and non‐neural cells. J Biol Chem 272: 6641–6646. [DOI] [PubMed] [Google Scholar]
  • 45. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11: 575–580. [DOI] [PubMed] [Google Scholar]
  • 46. Roe MT, Dawson DV, Hulette CM, Einstein G, Crain BJ (1996) Microglia are not exclusively associated with plaque‐rich regions of the dentate gyrus in Alzheimer's disease. J Neuropathol Exp Neurol 55: 366–371. [DOI] [PubMed] [Google Scholar]
  • 47. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, Kogan F (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43: 1609–1611. [DOI] [PubMed] [Google Scholar]
  • 48. Roses AD (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: beta‐amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 53: 429–437. [DOI] [PubMed] [Google Scholar]
  • 49. Roses AD (1996) Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 47: 387–400. [DOI] [PubMed] [Google Scholar]
  • 50. Rozemuller JM, Eikelenboom P, Stam FC, Beyreuther K, Masters CL (1989) A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol 48: 674–691. [DOI] [PubMed] [Google Scholar]
  • 51. Saitoh T, Kang D, Mallory M, Deteresa R, Masliah E (1997) Glial cells in Alzheimer's disease: preferential effect of APOE risk on scattered microglia. Gerontology 43: 109–118. [DOI] [PubMed] [Google Scholar]
  • 52. Saunders AM, Strittmatter WJ, Schmechel D, St. George‐Hyslop PH, Pericak‐Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper‐MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele epsilon‐4 with late‐onset familial and sporadic Alzheimer's disease. Neurology 43: 1467–1472. [DOI] [PubMed] [Google Scholar]
  • 53. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak‐Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid b‐peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late‐onset Alzheimer disease. Proc Natl Acad Sci USA 90: 9649–9653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Shigematsu K, McGeer PL, Walker DG, Ishii T, McGeer EG (1992) Reactive microglia/macrophages phagocytose amyloid precursor protein produced by neurons following neural damage. J Neurosci Res 31: 443–453. [DOI] [PubMed] [Google Scholar]
  • 55. Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Hajian H, Finch CE (1997) Astrocytes and microglia respond to estrogen with increased APOE mRNA in vivo and in vitro. Exp Neurol 143: 313–318. [DOI] [PubMed] [Google Scholar]
  • 56. Streit WJ, Graeber MB, Kreutzberg GW (1989a) Expression of la antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury. Exp Neurol 105: 115–126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Streit WJ, Graeber MB, Kreutzberg GW (1989b) Peripheral nerve lesion produces increased levels of major histocompatibility complex antigens in the central nervous system. J Neuroimmunol 21: 117–123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Strittmatter WJ, Saunders AM, Schmechel D, Pericak‐Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: High‐avidity binding to b‐amyloid and increased frequency of type 4 allele in late‐onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977–1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Uchihara T, Duyckaerts C, He Y, Kobayashi K, Seilhean D, Amouyel P, Hauw JJ (1995) APOE immunoreactivity and microglial cells in Alzheimers disease brain. Neuroscience Letters 1: 5–8. [DOI] [PubMed] [Google Scholar]
  • 60. Yan SD, Chen X, Fu J, Chen M, Zhu HJ, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid‐beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685–691. [DOI] [PubMed] [Google Scholar]
  • 61. Yan SD, Zhu HJ, Fu J, Yan SF, Roher A, Tourtellotte WW, Rajavashisth T, Chen X, Godman GC, Stern D, Schmidt AM (1997) Amyloid‐beta peptide‐receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage‐colony stimulating factor: A proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci USA 10: 5296–5301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Zubenko GS, Stiffler S, Stabler S, Kopp U, Hughes HB, Cohen BM, Moossy J (1994) Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy‐confirmed Alzheimer's disease. Am J Med Genet 54: 199–205. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES